These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

421 related items for PubMed ID: 10320529

  • 21. Inulin and fructo-oligosaccharides differ in their ability to enhance the density of cancellous and cortical bone in the axial and peripheral skeleton of growing rats.
    Nzeusseu A, Dienst D, Haufroid V, Depresseux G, Devogelaer JP, Manicourt DH.
    Bone; 2006 Mar; 38(3):394-9. PubMed ID: 16249132
    [Abstract] [Full Text] [Related]

  • 22. Bone mass development and bone metabolism in juvenile idiopathic arthritis: treatment with growth hormone for 4 years.
    Bechtold S, Ripperger P, Bonfig W, Schmidt H, Bitterling H, Häfner R, Schwarz HP.
    J Rheumatol; 2004 Jul; 31(7):1407-12. PubMed ID: 15229964
    [Abstract] [Full Text] [Related]

  • 23. A school curriculum-based exercise program increases bone mineral accrual and bone size in prepubertal girls: two-year data from the pediatric osteoporosis prevention (POP) study.
    Linden C, Ahlborg HG, Besjakov J, Gardsell P, Karlsson MK.
    J Bone Miner Res; 2006 Jun; 21(6):829-35. PubMed ID: 16753013
    [Abstract] [Full Text] [Related]

  • 24. The impact of idiopathic childhood-onset growth hormone deficiency (GHD) on bone mass in subjects without adult GHD.
    Lange M, Müller J, Svendsen OL, Kastrup KW, Juul A, Feldt-Rasmussen U.
    Clin Endocrinol (Oxf); 2005 Jan; 62(1):18-23. PubMed ID: 15638865
    [Abstract] [Full Text] [Related]

  • 25. The effect of growth hormone treatment on bone mineral density in prepubertal girls with Turner syndrome: a multicentre prospective clinical trial.
    Aycan Z, Cetinkaya E, Darendeliler F, Vidinlisan S, Bas F, Bideci A, Demirel F, Darcan S, Buyukgebiz A, Yildiz M, Berberoglu M, Bundak R.
    Clin Endocrinol (Oxf); 2008 May; 68(5):769-72. PubMed ID: 17980015
    [Abstract] [Full Text] [Related]

  • 26. Effects of skeletal size of the lumbar spine on areal bone density, volumetric bone density, and the diagnosis of osteoporosis in postmenopausal women in China.
    Liao EY, Wu XP, Liao HJ, Zhang H, Peng J.
    J Bone Miner Metab; 2004 May; 22(3):270-7. PubMed ID: 15108071
    [Abstract] [Full Text] [Related]

  • 27. Enhanced bone mass and physical fitness in young female handball players.
    Vicente-Rodriguez G, Dorado C, Perez-Gomez J, Gonzalez-Henriquez JJ, Calbet JA.
    Bone; 2004 Nov; 35(5):1208-15. PubMed ID: 15542047
    [Abstract] [Full Text] [Related]

  • 28. [Long-term effects of 7-year growth hormone substitution on bone metabolism, bone density, and bone quality in growth hormone-deficient adults].
    Wilhelm B, Kann PH.
    Med Klin (Munich); 2004 Oct 15; 99(10):569-77. PubMed ID: 15490072
    [Abstract] [Full Text] [Related]

  • 29. Effect of long-term growth hormone treatment on bone mass and bone metabolism in growth hormone-deficient men.
    Bravenboer N, Holzmann PJ, ter Maaten JC, Stuurman LM, Roos JC, Lips P.
    J Bone Miner Res; 2005 Oct 15; 20(10):1778-84. PubMed ID: 16160735
    [Abstract] [Full Text] [Related]

  • 30. On exposure to anorexia nervosa, the temporal variation in axial and appendicular skeletal development predisposes to site-specific deficits in bone size and density: a cross-sectional study.
    Seeman E, Karlsson MK, Duan Y.
    J Bone Miner Res; 2000 Nov 15; 15(11):2259-65. PubMed ID: 11092408
    [Abstract] [Full Text] [Related]

  • 31. Sexual dimorphism in cortical bone size and strength but not density is determined by independent and time-specific actions of sex steroids and IGF-1: evidence from pubertal mouse models.
    Callewaert F, Venken K, Kopchick JJ, Torcasio A, van Lenthe GH, Boonen S, Vanderschueren D.
    J Bone Miner Res; 2010 Mar 15; 25(3):617-26. PubMed ID: 19888832
    [Abstract] [Full Text] [Related]

  • 32. Measurement of volumetric bone mineral density accurately determines degree of lumbar undermineralization in children with growth hormone deficiency.
    Baroncelli GI, Bertelloni S, Ceccarelli C, Saggese G.
    J Clin Endocrinol Metab; 1998 Sep 15; 83(9):3150-4. PubMed ID: 9745418
    [Abstract] [Full Text] [Related]

  • 33. Validation of peripheral dual-energy X-ray absorptiometry for the measurement of bone mineral in intact and excised long bones of rats.
    Nagy TR, Prince CW, Li J.
    J Bone Miner Res; 2001 Sep 15; 16(9):1682-7. PubMed ID: 11547838
    [Abstract] [Full Text] [Related]

  • 34. Males have larger skeletal size and bone mass than females, despite comparable body size.
    Nieves JW, Formica C, Ruffing J, Zion M, Garrett P, Lindsay R, Cosman F.
    J Bone Miner Res; 2005 Mar 15; 20(3):529-35. PubMed ID: 15746999
    [Abstract] [Full Text] [Related]

  • 35. Interpretation of calcaneus dual-energy X-ray absorptiometry measurements in the assessment of osteopenia and fracture risk.
    Wren TA, Yerby SA, Beaupré GS, Carter DR.
    J Bone Miner Res; 2000 Aug 15; 15(8):1573-8. PubMed ID: 10934656
    [Abstract] [Full Text] [Related]

  • 36. Growth patterns at distal radius and tibial shaft in pubertal girls: a 2-year longitudinal study.
    Wang Q, Alén M, Nicholson P, Lyytikäinen A, Suuriniemi M, Helkala E, Suominen H, Cheng S.
    J Bone Miner Res; 2005 Jun 15; 20(6):954-61. PubMed ID: 15883635
    [Abstract] [Full Text] [Related]

  • 37. The Impact of congenital, severe, untreated growth hormone (GH) deficiency on bone size and density in young adults: insights from genetic GH-releasing hormone receptor deficiency.
    Maheshwari HG, Bouillon R, Nijs J, Oganov VS, Bakulin AV, Baumann G.
    J Clin Endocrinol Metab; 2003 Jun 15; 88(6):2614-8. PubMed ID: 12788864
    [Abstract] [Full Text] [Related]

  • 38. Timing of growth hormone treatment affects trabecular bone microarchitecture and mineralization in growth hormone deficient mice.
    Kristensen E, Hallgrímsson B, Morck DW, Boyd SK.
    Bone; 2010 Aug 15; 47(2):295-300. PubMed ID: 20399917
    [Abstract] [Full Text] [Related]

  • 39. Administration of growth hormone in selectively protein-deprived rats decreases BMD and bone strength.
    Ammann P, Brennan TC, Mekraldi S, Aubert ML, Rizzoli R.
    Bone; 2010 Jun 15; 46(6):1574-81. PubMed ID: 20178866
    [Abstract] [Full Text] [Related]

  • 40. Estrogen agonist (zeranol) treatment in a castrated male lamb model: effects on growth and bone mineral accretion.
    Chanetsa F, Hillman LS, Thomas MG, Keisler DH.
    J Bone Miner Res; 2000 Jul 15; 15(7):1361-7. PubMed ID: 10893685
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.